We repert the preduction, screening, and characterizatien of ten murine monodonal antibodies directed at antigens that are expressed abnormally in human breast tumors. Immunoperoxidase staining of frozen and fixed tissues shows the antigens to be present at low levels on the luminal membrane of normal breast cells and at high levels in the cytoplasm and surface membrane ofbreast tumor cells. The ten antibodies appear to recognize six different epitopes on the basis of their quantitative differences in reactivity against four antigen preparations, as measured by ELISA.
Introduction
Breast cancer originates in the tissue responsible for milk secretion. Synthesis and processing of the membrane components involved in milk secretion are complex (22) and involve insertion in the apical membrane of more than 30 proteins (18) . Several investigators have reported the production of antibodies to components of the apical membrane of breast cells (1, 6, 8, 10, 11, 15, 20, 24, 27, 33, 36) . The expression ofcertain ofthese antigens in breast tumors is abnormal. We report the production and detailed histological characterization of monoclonal antibodies (19) to components of human breast cell apical membrane that are abnormally PQ, Canada H3G 1Y6.
Seven antibodies react with an antigen from milk fat globule membrane of 330,000 MW. It therefore appears that the two molecules from tumor tissue and the one molecule from normal tissue share common epitopes.
Selected antibodies were tested for reactivity against 25 primary breast tumors and 14 pairs of primary and metastatic breast tumors. Three antibodies have broad reactivity and stain more than 80% of primary tumors; the three other anti- expressed and distributed in breast tumors. These antibodies consistently identify a characteristic set of antigens found in both primary and metastatic breast tumors, as well as in the sera of patients with disseminated disease. They also reveal a specific difference between the molecular weight of the antigenic material from tumors and that found in normal cells. Figure  3) ; prolonged exposure to the DAB solution also fails to reveal a higher MW band but results only in broadening of the bands and diffuse darkening ofthe nitrocellulose paper ( Figure  3) . Similarly, the overloading and overexposure ofMFGM blots do not reveal the lower MW bands of 280,000 or 300,000 seen in tumor membrane preparations ( Figure  3 ). The 280,000 MW and 300,000 MW molecules were detected in the four primary and six metastatic lesions examined. Antigens of identical MW were seen in the MCF-7 breast tumor cell line. These findings are illustrated in Figure 4 with antibodies from group II, III, and V reacted with protein blots of extracts from two primaries, one metastatic lesion, and the MCF-7 cell line. to the apical membrane ( Figure  6C ). There is heterogeneous reactivity in normal tissue, where most acini and ducts are negative when stained with any of the antibodies. This is in contrast to secretory breast tissue, where reactivity is stronger in most acini and ducts ( Figure  6B ) but is still limited to the apical membrane, . U.
Materials and Methods

I-is
I.; with no staining of lateral or basal membrane or of cytoplasm. -- Figure  7a ) on many samples. There is variation in the percentage of cells stained in the primary lesion and in the corresponding metastatic lesion. The proportion of cells stained in a tumor also varies between antibodies. Cytoplasmic staining ( Figure  7b) is seen in 11 primary lesions. Peripheral accentuation ( Figure  7c) is detected in the other three primary lesions;
the corresponding metastatic lesions show cytoplasmic staining without any peripheral accentuation.
Immunofluorescence was used to test each antibody for reactivity with the human breast tumor cell line MCF-7, both before and after a 5-mm treatment of the cells with 0.05% trypsin ( 
Tumor preparation
MB) was extracted with methanol and then assayed by ELISA for immunoreactivity. The methanol-treated antigen did not show a loss of immunoreactivity with antibodies MA2, MA), and MA8 (Table 6 ).
Discussion
The In this report, we are interested primarily in expres-sion and characterization of these antigens in breast tumors as well as in normal tissue.
Previously reported monoclonal antibodies to antigens of breast tumors can be assigned to two groups on the basis of the MW of the antigens recognized (3, 4, 6, 15, 20, 23, 26, 28) 
